<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.eurjmedres.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>European Journal of Medical Research - Latest Articles</title>
        <link>http://www.eurjmedres.com</link>
        <description>The latest research articles published by European Journal of Medical Research</description>
        <dc:date>2013-05-17T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/14" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/13" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/12" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/11" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/10" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/9" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/8" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/7" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/6" />
                                <rdf:li rdf:resource="http://www.eurjmedres.com/content/18/1/5" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/14">
        <title>Roles of virulence genes (PsaA and CpsA) on the invasion of Streptococcus pneumoniae into blood system</title>
        <description>Background:
Streptococcus pneumoniae (SP) is the major cause of childhood mortality worldwide, we need to understand virulence genes of SP so can better target the treatment.We investigated the expression of virulence genes PsaA and CpsA in different strains of SP interacting with monocyte cell line (THP-1) or pneumocyte cell line (A549) and the possible mechanism of SP invasion of the blood system.
Methods:
A total of 23 strains of SP were collected from hospitalized patients (blood-derived and sputum-derived) in the Second Affiliated Hospital of Wenzhou Medical College. The strains and ATCC 49619 were cultured, and RNAs were extracted. THP-1 and A549 cells were stimulated by different SP and ATCC 49619 for 4 h and 8 h, respectively. Quantitative real-time PCR was used to analyze the mRNA expression of PsaA and CpsA. The data were analyzed by SPSS 17.0.
Results:
The mRNA level of PsaA and CpsA were all significantly increased in clinical SP strains when compared to ATCC49619 after tedTHP-1 and A549 cells were stimulated . Clinical SPs showed higher virulence compared with ATCC49619.
Conclusions:
The expression of CpsA is the basis of the pathogenicity of SP. The expression of virulence gene PsaA may be helpful to the invasion of SP to the blood system.</description>
        <link>http://www.eurjmedres.com/content/18/1/14</link>
                <dc:creator>Da-kang Hu</dc:creator>
                <dc:creator>Dong-guo Wang</dc:creator>
                <dc:creator>Yang Liu</dc:creator>
                <dc:creator>Chi-bo Liu</dc:creator>
                <dc:creator>Lian-hua Yu</dc:creator>
                <dc:creator>Ying Qu</dc:creator>
                <dc:creator>Xin-hua Luo</dc:creator>
                <dc:creator>Jin-hong Yang</dc:creator>
                <dc:creator>Jian Yu</dc:creator>
                <dc:creator>Jin Zhang</dc:creator>
                <dc:creator>Xiang-yang Li</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:14</dc:source>
        <dc:date>2013-05-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-14</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-14-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2013-05-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/13">
        <title>Endometriosis of the lung: report of a case and literature review</title>
        <description>This paper reports a case of endometriosis of the lung in a 29-year-old woman with long-term periodic catamenial hemoptysis. A chest computed tomography image obtained during menstruation revealed a radiographic opaque lesion in the lingular segment of the left superior lobe. During bronchoscopy, bleeding in the mucosa of the distal bronchus of the lingular segment of the left superior lobe was observed. Histopathology subsequent to an exploratory thoracotomy confirmed the diagnosis of endometriosis of the left lung. The 2-year follow-up after lingular lobectomy of the left superior lobe showed no recurrence or complications.</description>
        <link>http://www.eurjmedres.com/content/18/1/13</link>
                <dc:creator>Haidong Huang</dc:creator>
                <dc:creator>Chen Li</dc:creator>
                <dc:creator>Paul Zarogoulidis</dc:creator>
                <dc:creator>Kaid Darwiche</dc:creator>
                <dc:creator>Nikolaos Machairiotis</dc:creator>
                <dc:creator>Lixin Yang</dc:creator>
                <dc:creator>Michael Simoff</dc:creator>
                <dc:creator>Eduardo Celis</dc:creator>
                <dc:creator>Tiejun Zhao</dc:creator>
                <dc:creator>Konstantinos Zarogoulidis</dc:creator>
                <dc:creator>Nikolaos Katsikogiannis</dc:creator>
                <dc:creator>Wolfgang Hohenforst-Schmidt</dc:creator>
                <dc:creator>Qiang Li</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:13</dc:source>
        <dc:date>2013-05-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-13</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-13-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2013-05-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/12">
        <title>Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity</title>
        <description>Adipose tissue is still regarded as a principle site for lipid storage and mobilizing tissue with an important role in the control of energy homeostasis. Additionally, adipose tissue-secreted hormones such as leptin, visfatin, resistin, apelin, omentin, sex steroids, and various growth factors are now regarded as a functional part of the endocrine system. These hormones also play an important role in the immune system. Several in vitro and in vivo studies have suggested the complex role of adipocyte-derived hormones in immune system and inflammation. Adipokines mediate beneficial and detrimental effects in immunity and inflammation. Many of these adipocytokines have a physiological role in metabolism. The uncontrolled secretions of several adipocytokines were associated with the stimulation of inflammatory processes leading to metabolic disorders including obesity, atherosclerosis, insulin resistance and type 2 diabetes. Obesity leads to the dysfunction of adipocytes andcorrelated with the imbalance of adipokines levels. In obese and diabetic conditions, leptin deficiency inhibited the Jak/Stat3/PI3K and insulin pathways. In this review, ample evidence exists to support the recognition of the adipocyte&#8217;s role in various tissues and pathologies. New integral insights may add dimensions to translate any potential agents into the future clinical armamentarium of chronic endocrine metabolic and inflammatory diseases. Functional balance of both adipocytes and immune cells is important to exert their effects on endocrine metabolic disorders; furthermore, adipose tissue should be renamed not only as a functional part of the endocrine system but also as a new part of the immune system.</description>
        <link>http://www.eurjmedres.com/content/18/1/12</link>
                <dc:creator>Ebtesam AL-Suhaimi</dc:creator>
                <dc:creator>Adeeb Shehzad</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:12</dc:source>
        <dc:date>2013-05-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-12</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-12-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2013-05-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/11">
        <title>Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China</title>
        <description>Background:
The aim of the study was to test for human papilloma virus (HPV) infection and human telomerase RNA component (hTERC) gene amplification in tissues derived from esophageal cancer, in esophagus displaying atypical hyperplasia and in normal tissue, and to analyze the relationship between them and discuss whether HPV infection and hTERC gene amplification play a role in the duration of survival of esophageal cancer patients.
Methods:
To test for HPV infection, surface plasma resonance was used after extracting and subjecting the DNA to PCR amplification. Measurement of hTERC gene amplification was performed by the fluorescence in situ hybridization technique.
Results:
The rates of HPV infection in the normal group, the atypical esophageal hyperplasia group and the cancer group were 0% (0/40), 10.00% (1/10) and 20.65% (19/92), respectively, with a statistically significant difference of P &lt; 0.01. The hTERC gene amplification rate in normal tissue, grade I atypical hyperplastic tissue, grade II/III atypical hyperplastic tissue and esophageal cancer tissue were 0% (0/89), 15.38% (4/26), 47.06% (8/17) and 89.13% (82/92), respectively, with a statistically significant difference of P &lt; 0.01. On follow-up of 92 patients, survival curves of the HPV-positive and HPV-negative groups were not significantly different (P &gt; 0.05). Survival curves of the hTERC gene amplification-positive and hTERC gene amplification-negative groups were statistically significant (P &lt; 0.05). A matching chi-square test showed that there was no correlation between HPV infection and hTERC gene amplification (P &gt; 0.05).
Conclusion:
HPV infection may be one of many factors contributing to the development of esophageal cancer, but it does not influence prognosis. Amplification of the hTERC gene appears to influence certain features associated with postoperative survival in esophageal carcinoma patients.</description>
        <link>http://www.eurjmedres.com/content/18/1/11</link>
                <dc:creator>Yu-Feng Wang</dc:creator>
                <dc:creator>Xin-Shuai Wang</dc:creator>
                <dc:creator>She-Gan Gao</dc:creator>
                <dc:creator>Qiang Chen</dc:creator>
                <dc:creator>Yan-Tong Yang</dc:creator>
                <dc:creator>Zhong-Yue Xiao</dc:creator>
                <dc:creator>Xiu-Qing Peng</dc:creator>
                <dc:creator>Xiu-Feng Hu</dc:creator>
                <dc:creator>Qia-Yin Wang</dc:creator>
                <dc:creator>Xiao-Shan Feng</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:11</dc:source>
        <dc:date>2013-05-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-11</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-11-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2013-05-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/10">
        <title>Polymorphism of ZBTB17 gene is associated with idiopathic dilated cardiomyopathy: a case control study in a Han Chinese population</title>
        <description>Background:
Dilated cardiomyopathy (DCM) has been extensively investigated for many years, but its pathogenesis remains uncertain. The ACTC1 gene was the first sarcomeric gene whose mutation was shown to cause DCM; recent studies have indicated that the HSPB7 and ZBTB17 genes are also associated with DCM. To assess the potential role of these three genes in DCM, we examined 11 single nucleotide polymorphisms (SNPs) in the ZBTB17, HSPB7 and ACTC1 genes: namely, rs10927875 in ZBTB17; rs1739843, rs7523558, and rs6660685 in HSPB7; rs533021, rs589759, rs1370154, rs2070664, rs3759834, rs525720 and rs670957 in ACTC1.
Methods:
A total of 97 DCM patients and 189 controls were included in the study. All SNPs were genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
Results:
The genotype of SNP rs10927875 in ZBTB17 (OR=5.19, 95% CI =1.00 to 27.03, P=0.05) was associated with DCM in a Han Chinese population. There was no difference in genotype or allele frequencies in ACTC1 or HSPB7 between DCM patients and control subjects.
Conclusion:
The ZBTB17 polymorphism rs10927875 appears to play a role in the susceptibility of the Han Chinese population to DCM.</description>
        <link>http://www.eurjmedres.com/content/18/1/10</link>
                <dc:creator>Xiaoping Li</dc:creator>
                <dc:creator>Rong Luo</dc:creator>
                <dc:creator>Xiaoyang Mo</dc:creator>
                <dc:creator>Rongjian Jiang</dc:creator>
                <dc:creator>Hong Kong</dc:creator>
                <dc:creator>Wei Hua</dc:creator>
                <dc:creator>Xiushan Wu</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:10</dc:source>
        <dc:date>2013-04-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-10</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-10-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2013-04-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/9">
        <title>Evaluation of erythroblast macrophage protein related to erythroblastic islands in patients with hematopoietic stem cell transplantation</title>
        <description>Background:
Hematopoietic evaluation of the patients after Hematopoietic stem cell transplantation (HSCT) is very important. Erythroblast macrophage protein (Emp) is a key protein with function in normal differentiation of erythroid cells and macrophages. Emp expression correlates with erythroblastic island formation, a process widely believed to be associated with hematopoiesis in bone marrow. We aimed to investigate the hematopoietic function of bone marrow from 46 HSCT patients and 16 inpatients with severe anemia applied to the treatment of EPO by measuring Emp expression level.
Methods:
Emp mRNA and protein expression levels in mononuclear cells of bone marrow and peripheral blood samples were detected by RT-PCR and Western blotting method respectively.
Results:
While hematopoiesis occurs in bone marrow, Emp expression level was elevated and more erythroblastic islands were found , and Emp is upregulated in bone marrow in response to erythropoietin (EPO) treatment.
Conclusions:
Emp expression correlates with erythroblastic island formation and has an important function for bone marrow hematopoiesis. Emp could be a potential biomarker for hematopoietic evaluation of HSCT patients.</description>
        <link>http://www.eurjmedres.com/content/18/1/9</link>
                <dc:creator>Xiaolu Mao</dc:creator>
                <dc:creator>Xiaoyan Shi</dc:creator>
                <dc:creator>Feng Liu</dc:creator>
                <dc:creator>Guining Li</dc:creator>
                <dc:creator>Lihua Hu</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:9</dc:source>
        <dc:date>2013-04-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-9</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-9-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2013-04-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/8">
        <title>Tracheal stenting for primary tracheal mucosa-associated lymphoid tissue lymphoma</title>
        <description>Primary tracheal mucosa-associated lymphoid tissue (MALT) lymphoma is extremely rare. We report a 49-year-old female patient with the complaint of dyspnea. Fiberoptic bronchoscopy showed polypoid, variable-sized and irregular nodules causing narrowing of the tracheal lumen from the proximal trachea to the left main bronchus. Because of severe stenosis in the airway and the severity of symptoms, this case was unresectable. The patient was then treated successfully with placement of an endobronchial stent through bronchofibroscopy. After the placement of the stent, bronchoscopic biopsy was performed. Pathological analysis confirms a diagnosis of MALT-associated malignant lymphoma. We performed systemic chemotherapy on the patient. The temporary stent was removed after the reduction of the stenosis. This is the first case in which tracheal MALT lymphoma was treated successfully following tracheal stent insertion guided by bronchofibroscopy. Temporary tracheal stenting can be a favorable choice for a patient with tracheal stenosis caused by primary tracheal MALT lymphoma.</description>
        <link>http://www.eurjmedres.com/content/18/1/8</link>
                <dc:creator>Juanjuan Ding</dc:creator>
                <dc:creator>Zhuochang Chen</dc:creator>
                <dc:creator>Manli Shi</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:8</dc:source>
        <dc:date>2013-04-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-8</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-8-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2013-04-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/7">
        <title>A case of bilateral pleural effusion as the first sign of multiple myeloma</title>
        <description>Multiple myeloma (MM) is a type of hematological malignancy that can affect all types of tissues in human. However, it is extremely rare that pleural effusion presents as the first sign in MM patients. A 54-year-old male patient attended our department of respiratory medicine complaining of shortness of breath for the past 3 months. A chest computer tomography (CT) radiograph revealed a bilateral pleural effusion, which was further assessed as exudative type. Sinus spiral CT scan demonstrated diffuse bone destruction of craniofacial bone. A broad reduction of the lumbar bone signal was confirmed by MRI. Furthermore, pleural biopsy showed abnormal proliferation of plasmocytes whereas bone marrow biopsy showed active hyperplasia of plasmacytoid cells. Interestingly, Bence-Jones protein in urine and serum protein electrophoresis was negative. The patient was diagnosed as non-secretory MM. He then underwent chemotherapy with vincristine, adriamycin and dexamethasone. Partial regression of the pleural effusion was achieved after two rounds of chemotherapy, and the patient has been followed for more than one year.</description>
        <link>http://www.eurjmedres.com/content/18/1/7</link>
                <dc:creator>Xuan-li Xu</dc:creator>
                <dc:creator>Yi-hong Shen</dc:creator>
                <dc:creator>Qian Shen</dc:creator>
                <dc:creator>Jian-ying Zhou</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:7</dc:source>
        <dc:date>2013-03-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-7</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-7-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2013-03-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/6">
        <title>Level of information about the relationship between diabetes mellitus and periodontitis - results from a nationwide diabetes information program</title>
        <description>Background:
A comprehensive knowledge about the mutual influence between diabetes and periodontitis is decisive for the successful treatment of both diseases. The present investigation aimed at assessing the diabetic and periodontal conditions and, in particular, the degree of knowledge about the relationship between diabetes and periodontitis.
Methods:
During a diabetes information program, 111 nondiabetics (ND), 101 type 1 diabetics (T1D), and 236 type 2 diabetics (T2D) were subject to a medical and dental examination and completed a self-administered questionnaire. Medical examination included measurements of glycated hemoglobin (HbA1c), blood glucose (BG), and body mass index (BMI). Full-mouth examination consisted of the assessment of the decayed, missing, filled teeth index (DMFT) and the periodontal screening index (PSI). Chi-square test, ANOVA, t test of independent samples, univariate and multivariate logistic regression models with variable selection strategies were used for statistical analyses. Due to the exploratory character of the investigation a value of P &#8804;0.05 was considered to be statistically substantial.
Results:
T2D had a significantly higher PSI when compared to T1D and ND (t test: P &lt;0.001; P = 0.005). Approximately 90% of T2D suffered from periodontitis. In addition, diabetics with periodontitis showed a significantly higher BMI when compared to diabetics without periodontitis (multivariate logistic regression: P = 0.002). Almost 60% of all investigated subjects were not informed about the mutual influence between diabetes and periodontitis. T2D had almost as little information about the increased risk for periodontitis as ND.
Conclusions:
The data of the present investigation suggest that there is a strong association between type 2 diabetes and chronic periodontitis. The lack of awareness of the mutual influence between diabetes and periodontitis, especially in T2D, demonstrates that this topic is still neglected in dental and diabetic treatment.</description>
        <link>http://www.eurjmedres.com/content/18/1/6</link>
                <dc:creator>Knut Weinspach</dc:creator>
                <dc:creator>Ingmar Staufenbiel</dc:creator>
                <dc:creator>Sonja Memenga-Nicksch</dc:creator>
                <dc:creator>Stefanie Ernst</dc:creator>
                <dc:creator>Werner Geurtsen</dc:creator>
                <dc:creator>Hüsamettin Günay</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:6</dc:source>
        <dc:date>2013-03-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-6</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-6-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2013-03-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.eurjmedres.com/content/18/1/5">
        <title>Identification of drug candidate for osteoporosis by computational bioinformatics analysis of gene expression profile</title>
        <description>Background:
Osteoporosis is a condition of bones that leads to an increased susceptibility to fracture and consequent painful morbidity. It has become a major issue of life quality worldwide. However, until now, the molecular mechanism of this disease is far from being clear.
Methods:
In this study, we obtained the gene expression profile of osteoporosis and controls from Gene Expression Omnibus and identified differentially expressed genes (DEGs) using classical t-test method. Then, functional enrichment analyses were performed to identify the dysregulated Gene Ontology categories and dysfunctional pathways in osteoporosis patients compared to controls. Besides, the connectivity map was used to identify compounds that induced inverse gene changes to osteoporosis.
Results:
A total of 5581 DEGs were identified. We found these DEGs were enriched in 9 pathways by pathway enrichment analysis, including focal adhesion and MAPK signaling pathway. Besides, sanguinarine was identified as a potential therapeutic drug candidate capable of targeting osteoporosis.
Conclusion:
Although candidate agents identified by our approach may be premature for clinical trials, it is clearly a direction that warrants additional consideration.</description>
        <link>http://www.eurjmedres.com/content/18/1/5</link>
                <dc:creator>Guiyong Yu</dc:creator>
                <dc:creator>Litao Wang</dc:creator>
                <dc:creator>Yazhou Li</dc:creator>
                <dc:creator>Zhihong Ma</dc:creator>
                <dc:creator>Yu Li</dc:creator>
                <dc:source>European Journal of Medical Research 2013, null:5</dc:source>
        <dc:date>2013-03-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2047-783X-18-5</dc:identifier>
                                <prism:require>/content/figures/2047-783X-18-5-toc.gif</prism:require>
                <prism:publicationName>European Journal of Medical Research</prism:publicationName>
        <prism:issn>2047-783X</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2013-03-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
